Cadrenal Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2022 to Q3 2024.
  • Cadrenal Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.1M shares, a 7.56% increase year-over-year.
  • Cadrenal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 13.5M shares, a 71% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.1M +77.6K +7.56% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 16M +4.29M +36.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 16M +5.24M +48.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 13.5M +5.6M +71% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 1.03M -7.01M -87.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 11.7M +4M +51.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 10.8M +3.27M +43.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 7.89M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 8.04M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 7.72M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 7.5M Jan 25, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.